FDA Approves Phase II Trial of Combo Mesenchymal Stem Cell and Exosome Treatment of Pulmonary Fibrosis Secondary to Novel Corona Virus Infection (COVID-19) Vitti Labs, an AATB Accredited Tissue Bank focused on l...
As a result, I made a comprehensive list of FDA Approved Cell and Gene Therapies, which is the focus of today’s post. I’ve updated the list now in 2024 with the great news thatCasgevyandLyfgenia, gene therapies for sickle cell, are now approved as of late 2024. It’s exciting tha...
Yet, it was approved due to significant reductions in biomarkers associated with neuronal injury [10]. While biomarkers in neurodegenerative disease treatment have become pivotal in assessing therapeutic interventions, their reliability in predicting clinical outcomes has often needed to be more consistent....